Taysha Gene (TSHA) analyst forecast and price target
Analyst forecast
Consensus of 12 analyst ratings
Based on 6 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Goldman Sachs | Maintained | Buy | $13.00 from $11.00 | Jul 21, 2026 |
| Citizens | Maintained | Market Outperform | $11.00 | Jul 2, 2026 |
| Baird | Maintained | Outperform | $15.00 from $12.00 | Jun 30, 2026 |
| Needham | Maintained | Buy | $12.00 | Jun 30, 2026 |
| B of A Securities | Maintained | Buy | $10.00 from $9.00 | Jun 23, 2026 |
| BMO Capital | Maintained | Outperform | $14.00 from $10.00 | Jun 23, 2026 |
| Citizens | Maintained | Market Outperform | $11.00 from $8.00 | Jun 23, 2026 |
| Needham | Maintained | Buy | $12.00 | Jun 22, 2026 |
| Canaccord Genuity | Maintained | Buy | $17.00 from $14.00 | Apr 6, 2026 |
| Chardan Capital | Maintained | Buy | $12.00 | Mar 19, 2026 |
| Needham | Maintained | Buy | $12.00 from $10.00 | Mar 19, 2026 |
| Needham | Maintained | Buy | $10.00 | Mar 3, 2026 |
| Chardan Capital | Maintained | Buy | $12.00 | Jan 6, 2026 |
| Wells Fargo | Maintained | Overweight | $11.00 from $8.00 | Jan 5, 2026 |
| Chardan Capital | Maintained | Buy | $12.00 | Nov 5, 2025 |
| Citizens | Maintained | Market Outperform | $8.00 from $6.00 | Nov 5, 2025 |
| Raymond James | Initiated Coverage | Strong Buy | $13.00 | Oct 21, 2025 |
| Needham | Maintained | Buy | $10.00 | Oct 17, 2025 |
| Chardan Capital | Maintained | Buy | $12.00 | Oct 17, 2025 |
| Needham | Maintained | Buy | $10.00 from $8.00 | Oct 2, 2025 |
Frequently asked questions
What is the price target for TSHA stock?
The average 12-month analyst price target for Taysha Gene (TSHA) is $12.50, with a high estimate of $15.00 and a low of $10.00, across 6 analysts.
Is TSHA a buy, sell, or hold?
Analysts covering Taysha Gene currently average a Buy rating: 12 buy, 0 hold and 0 sell, from 12 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for TSHA?
The average price target of $12.50 implies 123.02% upside from the last price of $5.61.
What is the latest analyst rating on TSHA?
On Jul 21, 2026, Goldman Sachs maintained Taysha Gene at Buy with a price target of $13.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.